SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-027311
Filing Date
2022-05-17
Accepted
2022-05-16 19:12:56
Documents
164
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_allaritytherap.htm   iXBRL 10-K 3466729
2 DESCRIPTION OF CAPITAL STOCK f10k2021ex4vi_allarity.htm EX-4.VI 21999
3 ASSIGNMENT AND ASSUMPTION AGREEMENT BETWEEN ALLARITY THERAPEUTICS, INC. AND ALLA f10k2021ex10-17_allarity.htm EX-10.17 15910
4 EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20 f10k2021ex10-18_allarity.htm EX-10.18 365518
5 EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20 f10k2021ex10-19_allarity.htm EX-10.19 421623
6 AMENDED AND RESTATED LICENSE AGREEMENT AMONG ALLARITY THERAPEUTICS EUROPE APS, L f10k2021ex10-20_allarity.htm EX-10.20 178855
7 SUPPORT AGREEMENT BETWEEN ALLARITY THERAPEUTICS A/S AND LIPLASOME PHARMA APS, DA f10k2021ex10-21_allarity.htm EX-10.21 45496
8 SUBSIDIARIES OF THE REGISTRANT f10k2021ex21-1_allarity.htm EX-21.1 4749
9 CERTIFICATION f10k2021ex31-1_allarity.htm EX-31.1 11604
10 CERTIFICATION f10k2021ex31-2_allarity.htm EX-31.2 11472
11 CERTIFICATION f10k2021ex32-1_allarity.htm EX-32.1 5391
12 CERTIFICATION f10k2021ex32-2_allarity.htm EX-32.2 5014
13 GRAPHIC image_001.jpg GRAPHIC 28145
14 GRAPHIC image_002.jpg GRAPHIC 28145
15 GRAPHIC image_003.jpg GRAPHIC 94498
16 GRAPHIC image_004.jpg GRAPHIC 88321
17 GRAPHIC image_005.jpg GRAPHIC 60551
18 GRAPHIC image_006.jpg GRAPHIC 93547
19 GRAPHIC image_007.jpg GRAPHIC 125545
20 GRAPHIC image_008.jpg GRAPHIC 84324
21 GRAPHIC image_009.jpg GRAPHIC 38165
22 GRAPHIC image_010.jpg GRAPHIC 38165
23 GRAPHIC image_011.jpg GRAPHIC 63161
24 GRAPHIC image_012.jpg GRAPHIC 79792
25 GRAPHIC image_013.jpg GRAPHIC 82509
26 GRAPHIC image_014.jpg GRAPHIC 68098
27 GRAPHIC image_015.jpg GRAPHIC 90164
28 GRAPHIC image_016.jpg GRAPHIC 73654
29 GRAPHIC image_017.jpg GRAPHIC 62246
30 GRAPHIC image_018.jpg GRAPHIC 66707
31 GRAPHIC image_019.jpg GRAPHIC 53839
32 GRAPHIC image_020.jpg GRAPHIC 55908
33 GRAPHIC image_021.jpg GRAPHIC 37454
34 GRAPHIC image_022.jpg GRAPHIC 37155
35 GRAPHIC image_023.jpg GRAPHIC 74932
36 GRAPHIC image_024.jpg GRAPHIC 25167
37 GRAPHIC image_025.jpg GRAPHIC 30172
38 GRAPHIC image_026.jpg GRAPHIC 33430
39 GRAPHIC image_030.jpg GRAPHIC 17086
40 GRAPHIC image_031.jpg GRAPHIC 19954
41 GRAPHIC image_032.jpg GRAPHIC 25638
42 GRAPHIC image_033.jpg GRAPHIC 28611
43 GRAPHIC image_034.jpg GRAPHIC 19636
  Complete submission text file 0001213900-22-027311.txt   17622196

Data Files

Seq Description Document Type Size
44 XBRL SCHEMA FILE allr-20211231.xsd EX-101.SCH 133780
45 XBRL CALCULATION FILE allr-20211231_cal.xml EX-101.CAL 40889
46 XBRL DEFINITION FILE allr-20211231_def.xml EX-101.DEF 487069
47 XBRL LABEL FILE allr-20211231_lab.xml EX-101.LAB 931439
48 XBRL PRESENTATION FILE allr-20211231_pre.xml EX-101.PRE 512131
158 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_allaritytherap_htm.xml XML 1207093
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41160 | Film No.: 22931661
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences